The Medical and Scientific Team at Syndax Pharmaceuticals, Inc is responsible for overseeing the development and clinical evaluation of new combination therapies for cancer treatment. This includes conducting clinical trials, ensuring regulatory compliance, managing statistical analysis, and generating comprehensive medical documentation to support drug development and approval processes. The team collaborates closely to integrate scientific research with clinical expertise to advance Syndax’s product pipeline, particularly focusing on their lead candidate, entinostat.